Skip to main content

Table 3 Occurrence of decompensating event following viral eradication

From: Liver function following hepatitis C virus eradication by direct acting antivirals in patients with liver cirrhosis: data from the PITER cohort

  HCV/HIV co-infected (N = 11) HCV mono-infected (N = 114)
Patients with a pre-treatment history of decompensated cirrhosis N. % N. %
Ascites 6 85.7 32 52.5
Ascites + hepatic encephalopathy 0 0.0 8 13.1
Ascites + gastrointestinal bleeding 0 0.0 2 3.3
Ascites + gastrointestinal bleeding + hepatic encephalopathy 0 0.0 2 3.3
Hepatic encephalopathy 0 0.0 9 14.8
Gastrointestinal bleeding 1 14.3 8 13.1
TOTAL 7 100.0 61 100.0
Patients with incident decompensating event N. % N. %
Ascites 3 75.0 32 67.9
Ascites + hepatic encephalopathy 0 0.0 6 3.8
Hepatic encephalopathy 1 25.0 6 11.3
Gastrointestinal bleeding 0 0.0 9 17.0
TOTAL 4 100.0 53 100.0